| BUSINESS INFORMATION |
New production plant for pharmaceutical active ingredients to be built in Minden, Germany 05/22/03 P-03-258 BASF Aktiengesellschaft’s Fine Chemicals division is expanding its production site for pharmaceutical active ingredients in Minden, Germany, and is investing an eight-digit sum in the construction of a new multiproduct plant. The plant, which is expected to start operations in late 2004, will manufacture pharmaceutical active ingredients and intermediates in accordance with cGMP (current good manufacturing practice). Flexible equipment will allow rapid product changeovers and the use of new technologies. The Minden site is particularly suitable for the planned capital expenditure in view of its expertise and many years of experience in manufacturing and handling pharmaceutical active ingredients such as pseudoephedrine and caffeine. All the major European and U.S. regulatory authorities have repeatedly inspected and approved Minden as a production site for pharmaceutical ingredients. BASF employs approximately 730 people at the site. The Fine Chemicals division pursues a strategy of profitable growth in its Pharma Solutions business unit. A key aspect of this strategy is the expansion of pharma contract manufacturing. In 2002, the Pharma Solutions business unit posted sales of approximately €400 million. By 2010, BASF aims to achieve a leading position in this business. |
| UPDATE | 05.03 |
| COMPANY | BASF |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |